MARC Record from Library of Congress

LEADER: 02259cam a22003734a 4500
001 2008013482
003 DLC
005 20091026144025.0
008 080321s2008 nyua b 001 0 eng
010 $a 2008013482
020 $a9781604566208 (softcover)
035 $a(DNLM)101469459
040 $aDNLM/DLC$cDLC$dDLC
042 $apcc
050 00 $aQP106.6$b.A556 2008
060 10 $aWG 500$bA5859 2008
082 00 $a612.1/3$222
245 00 $aAngiogenesis research progress /$cThomas J. Lewis and James Robinson (editors).
260 $aNew York :$bNova Science Publishers,$cc2008.
300 $ax, 218 p. :$bill. (some col.) ;$c27 cm.
504 $aIncludes bibliographical references and index.
505 0 $aHeme oxigenase-1 and angiogenesis: therapeutic implications / Jòzef Dulak ... [et al.] -- Cancer therapy by angiogenesis inhibition: current status and future prospects / Elena Favaro, Alberto Amadori, Stefano Indraccolo -- Role of angiogenesis in the development of preneoplastic lesions in hepatocellular carcinoma / Hitoshi Yoshiji ... [et al.] -- Angiogenesis related factors in hepatocellular carcinoma and anti-angiogenesis therapy / Baomin Shi ... [et al.] -- Vaccines targeting tumor angiogenesis / Yurai Okaji ... [et al.] -- The role of endothelial progenitor cells in tumor angiogenesis / Domenico Ribatti -- Tumor angiogenesis in gallbladder cancer / Andréa Oxley Da Rocha, Lígia Maria Barbosa Coutinho, João Grigoletti Scholl -- Non-small cell lung cancer and angiogenesis / P. Sardari Nia, P. Van Schil -- Metastasis suppression by SSECKS/Gravin/AKA-P12 through the inhibition of distal angiogenesis / Irwin H. Gelman.
650 0 $aNeovascularization.
650 0 $aNeovascularization inhibitors$xTherapeutic use.
650 0 $aCell transformation.
650 12 $aNeovascularization, Physiologic.
650 22 $aAngiogenesis Inhibitors$xtherapeutic use.
650 22 $aCell Transformation, Neoplastic.
650 22 $aEndothelial Cells$xpathology.
650 22 $aNeoplasm Metastasis$xprevention & control.
650 22 $aNeovascularization, Pathologic.
700 1 $aLewis, Thomas J.,$d1959-
700 1 $aRobinson, James,$d1958-
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/toc/fy0906/2008013482.html